Somatic genetic alterations predict hematological progression in GATA2 deficiency.

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Germline GATA2 mutations are linked to myeloid malignancies.
• These mutations lead to progressive acquisition of somatic mutations.

Purpose of the Study:

• To characterize the clinical and biological features of 78 GATA2-deficient patients.
• To identify specific somatic mutations associated with disease progression in GATA2 syndrome.

Main Methods:

• Phenotypic characterization of hematopoietic stem and progenitor cells.
• Analysis of somatic mutations (STAG2, ASXL1, SETBP1, RAS pathway, RUNX1) and cytogenetic abnormalities.
• Classification of patients into three hematopoietic spectra based on bone marrow cytomorphology.

Main Results:

• Exhaustion of myeloid progenitors observed in GATA2-deficient patients.
• Frequent somatic mutations (STAG2, ASXL1, SETBP1) and cytogenetic abnormalities (monosomy 7, trisomy 8, der(1;7)) found.
• Spectrum 0: No somatic mutations. Spectrum 1: STAG2 mutations with hypocellular/myelodysplastic bone marrow. Spectrum 2: SETBP1, RAS, RUNX1 mutations associated with leukemic transformation.

Conclusions:

• Specific somatic alterations are associated with distinct clinical and hematological evolution in GATA2 syndrome.
• Somatic genetic profiling can aid in patient management and understanding leukemogenesis in GATA2 mutations.